Chronos Therapeutics

Chronos is a CNS specialist company with a high concentration of expertise in both degenerative and behavioural diseases of the brain and nervous system.

What we do: Chronos is an Oxford-based biotechnology company operating a semi-virtual research and development model to develop a portfolio of therapies in degenerative and behavioral brain diseases. The team utilises a network of industry-leading contract research organisations to develop NCEs and repurpose existing launched drugs. Chronos also has a dedicated laboratory in Oxford which screens for activity of drugs in brain disease through its proprietary platform, Chronoscreen.

Our Focus:
- Acquisition, discovery and development of novel proprietary lead candidates.
- Repositioning FDA/EMA approved drugs.

Targets:
- ALS (Lou Gehrig’s Disease)
- Other Neurological Diseases
- Fatigue
- Addictive Behaviour